SCHEMBL8808477

SCHEMBL8808477

O=C(O)CCN1N=C(c2c(-c3ccccc3)nn3ccccc23)CCC1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.53
PDE4B Q07343 1/20 0.51
KMT2A Q03164 2/20 0.46
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.40
LMNA P02545 1/20 0.40
AKT1 P31749 1/20 0.40
IGF1R P08069 1/20 0.39
THRB P10828 1/20 0.39
EGFR P00533 1/20 0.39
KDM4E B2RXH2 2/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8808435 0.89 PDE4B (0.49) ADORA1PDE4BKMT2AMAPK1SMN1; SMN2
SCHEMBL8808458 0.74 ADORA1 (0.52) ADORA1KMT2AMAPK1POLBAKT1
SCHEMBL8807266 0.73 ADORA1 (0.88) ADORA1MAPK1AKT1IGF1RKDM4E
SCHEMBL8808264 0.73 ADORA1 (0.59) ADORA1PDE4BMAPK1AKT1IGF1R
SCHEMBL8807259 0.72 ADORA1 (0.57) ADORA1MAPK1AKT1IGF1REGFR
SCHEMBL8808089 0.71 ADORA1 (0.64) ADORA1MAPK1AKT1IGF1REGFR
SCHEMBL8811466 0.71 PDE4B (0.67) ADORA1PDE4BMAPK1SMN1; SMN2AKT1
SCHEMBL8809176 0.70 ADORA1 (0.52) ADORA1MAPK1AKT1IGF1REGFR
SCHEMBL2641189 0.69 ADORA1 (1.00) ADORA1MAPK1IGF1RKDM4ETSHR
SCHEMBL8807647 0.69 ADORA1 (0.94) ADORA1MAPK1IGF1RKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0379979-B1 Pyrazolopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1997-03-19 EP disclosed
US-5155114-A Treating or preventing renal toxicity, nephrosis, nephritis FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-10-13 US disclosed
US-4985444-A Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-01-15 US disclosed
EP-0379979-A1 Pyrazolopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-08-01 EP disclosed